News
Small Cap Stock news
-
GeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Update
[ad_1] Cancer Gene Therapy Program and Next-Generation COVID-19 Vaccine Advancing in Phase 2 Clinical Trials Company to Host Conference…
Read More » -
Movement Industries Corporation Launches Remote IoT Custom Skid Project
[ad_1] HOUSTON, TX – (NewMediaWire) – May 04, 2023 – Movement Industries Corporation (OTC PINK: MVNT) (the “Company”) has announced…
Read More » -
Snap Up Photography/Videography Studio Expands Across the United States
[ad_1] Miami, FL – (NewMediaWire) – May 3, 2023 – Snap Up Studio, a leading photography and videography studio specializing…
Read More » -
Martial Arts History Museum to celebrate AAPI with Self-Protection Device Give-Away
[ad_1] Martial arts teacher Michelle Manu leads the class on using the stun device (NewMediaWire) – May 03, 2023 –…
Read More » -
American Stroke Association names 2023 Stroke Heroes
[ad_1] (NewMediaWire) – May 03, 2023 – DALLAS — Six local stroke heroes from across the country are being recognized by…
Read More » -
PreIPO.com Unveils Cutting-Edge Fintech Tools at Pro Panama’s Inaugural Sustainable Investment Summit
[ad_1] PANAMA CITY, Republic of Panama – (NewMediaWire) – May 2, 2023 – (ACN Newswire) – Leading global fintech brand PreIPO…
Read More » -
ONERHT Foundation Appoints AlDigi Holdings CEO to Its Board of Directors
[ad_1] He is the Deputy Chairman and Co-Founder of SDAX Exchange, Director of carbon trading platform AirCabon Exchange, Director of…
Read More » -
QC Kinetix (Springs Medical): Louisville’s Go-to Regenerative Medicine Clinic for Evidence-based Treatments
[ad_1] Louisville, KY – (NewMediaWire) – May 2, 2023 – Pain affects people in different ways depending on how severe…
Read More » -
Splash Beverage Group and Idaho’s Stein Distributing in Agreement for Distribution of All Splash Brands
[ad_1] FORT LAUDERDALE, FL – (NewMediaWire) – May 02, 2023 – Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or…
Read More » -
OKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease
OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease…
Read More »
